Location History:
- Cambridge, GB (2001)
- West Wratting, GB (2002 - 2004)
Company Filing History:
Years Active: 2001-2004
Title: Kathryn Armour: Innovator in Monoclonal Antibodies
Introduction
Kathryn Armour is a distinguished inventor based in West Wratting, GB. She has made significant contributions to the field of biotechnology, particularly in the development of humanized monoclonal antibodies. With a total of 8 patents to her name, her work has the potential to impact cancer treatment and diagnostics.
Latest Patents
Among her latest patents are the high affinity humanized anti-TAG-72 monoclonal antibodies. These novel humanized monoclonal antibodies, along with their fragments and derivatives, specifically bind to TAG-72. The methods for their manufacture are also included in her patents. These humanized antibodies are particularly useful in treating cancers that express TAG-72, as well as for diagnostic purposes, such as in vivo imaging of tumors or cancer cells that express TAG-72.
Career Highlights
Kathryn Armour is currently associated with The Dow Chemical Company, where she continues to innovate in her field. Her work has garnered attention for its potential applications in medical science, particularly in oncology.
Collaborations
Some of her notable coworkers include W H Kerr Anderson and Philip Ronald Tempest. Their collaborative efforts contribute to the advancement of research in monoclonal antibodies.
Conclusion
Kathryn Armour's contributions to the field of biotechnology, particularly through her patents on humanized monoclonal antibodies, highlight her role as a leading inventor in cancer treatment and diagnostics. Her work continues to pave the way for innovative solutions in healthcare.